标题
Engineered nanomedicine for myeloma and bone microenvironment targeting
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 28, Pages 10287-10292
出版商
Proceedings of the National Academy of Sciences
发表日期
2014-07-01
DOI
10.1073/pnas.1401337111
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
- (2013) E. M. Pridgen et al. Science Translational Medicine
- Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
- (2012) Xue-Qing Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
- (2012) Nazila Kamaly et al. CHEMICAL SOCIETY REVIEWS
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
- (2012) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma
- (2012) Catherine A Taylor et al. MOLECULAR THERAPY
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects
- (2011) M. R. Reagan et al. CLINICAL CANCER RESEARCH
- Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid
- (2010) E. Terpos et al. ANNALS OF ONCOLOGY
- RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential
- (2010) Jayaraj Ravindran et al. BIOCHEMICAL PHARMACOLOGY
- Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway byNanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
- (2010) Diana Cirstea et al. MOLECULAR CANCER THERAPEUTICS
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Characterization and Cytotoxicity of Self-Organized Assemblies of Curcumin and Amphiphatic Poly(ethylene glycol)
- (2009) Keitaro Sou et al. Journal of Biomedical Nanotechnology
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started